Author

O. Shifman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Assay:bulk RNA-seq· 1 Assay:DNA methylation· 1 Organism:mouse· 1 Organism:virus· 1

Frequent Co-Authors

B. Politi· 3 shared H. Achdout· 3 shared H. Levy· 3 shared S. Lazar· 3 shared S. Melamed· 3 shared T. Israely· 3 shared A. Ben-Shmuel· 2 shared A. Beth-Din· 2 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

B. Politi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Monkeypox DNA correlates with virus infectivity in clinical samples

N. Paran, Y. Yahalom-Ronen, O. Shifman, S. Lazar, R. Ben-Ami, M. Yakubovsky, I. Levy, A. Wieder Feinsod, S. Amit, M. Katzir, N. Carmi Oren, A. Levcovich, M. Hershman-Sarafov, A. Paz, R. Thomas, , T. Israely

The paper correlates Monkeypox DNA content with virus infectivity in clinical samples and defines a PCR threshold for non-infectious virus.

bioRxiv · Aug 2, 2022 · PreprintMicrobiology

Mice with Induced Pulmonary Comorbidities Display Severe Lung Inflammation and Mortality following Exposure to SARS-CoV-2

R. Falach, L. Bar-On, S. Lazar, T. Kadar, O. Mazor, M. Aftalion, D. Gur, O. Shifman, O. Israeli, I. Cohen-Gihon, G. Zaide, H. Gutman, Y. Evgy, Y. Vagima, E. Makdasi, , T. Sabo

This study shows that CD-1 mice with induced pulmonary comorbidities develop severe lung inflammation and high mortality after SARS-CoV-2 infection.

bioRxiv · Oct 28, 2020 · PreprintPathology

A single dose of recombinant VSV-{triangleup}G-spike vaccine provides protection against SARS-CoV-2 challenge

Y. Yahalom-Ronen, H. Tamir, S. Melamed, B. Politi, O. Shifman, H. Achdout, E. B. Vitner, O. Israeli, E. Milrot, D. Stein, I. Cohen-Gihon, S. Lazar, H. Gutman, I. Glinert, L. Cherry, , T. Israely

This study develops a recombinant VSV-ΔG-spike vaccine that provides single-dose protection against SARS-CoV-2 in hamsters by inducing neutralizing antibodies and preventing lung pathology.

bioRxiv · Jun 18, 2020Microbiology